Oligodendrocytes, Glutamate Receptors, and Lead Neurotoxicity
Oligodendrocytes, Glutamate Receptors, and Lead Neurotoxicity
批准号:
8078963
负责人:
Wenbin Deng
金额:
$33.28万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-08-22 至 2013-05-31
关键词:
AMPA ReceptorsAcidsAffectAgeAnimalsAstrocytesBiochemicalBrainBuffersCa(2+)-Calmodulin Dependent Protein KinaseCalcineurinCell NucleusCell TransplantsCell physiologyCellsChildCognitive deficitsD AspartateDefectDevelopmentDevelopmental ProcessDiseaseEventFeedbackGene ExpressionGene SilencingGene TransferGlutamate ReceptorGlutamatesGoalsHippocampus (Brain)ImageImpairmentIn VitroInterventionIonsKainic Acid ReceptorsLeadLead PoisoningLearningLong-Term PotentiationMediatingMemoryMicroscopicMitochondriaMolecularMorphologyMyelinN-Methyl-D-Aspartate ReceptorsN-MethylaspartateNeuraxisNeurogliaNeurologicNeuronsOligodendrogliaOxidation-ReductionOxidative StressPhosphorylationPhysiologicalPlayPoisoningPredispositionPrincipal InvestigatorProcessRNA InterferenceRegulationRelative (related person)Research PersonnelRiskRoleSignal PathwaySignal TransductionSignaling MoleculeSliceSynapsesSynaptic plasticityTechniquesToxic effectUnited StatesVirusWorkage relatedcell typecellular targetingcopingdivalent metaleffusionexcitotoxicityfunctional disabilityin vivoin vivo Modelinsightkainatelead exposurelead ionmitochondrial dysfunctionneurobehavioralneurotoxicityneurotransmissionnoveloligodendrocyte precursorprogramsreceptorresearch studytoxicant
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant)
Lead (Pb2+) poisoning remains the most common disease of environmental origin in the United States today. The long-term goal is to investigate age-specific and cell type-specific mechanisms by which lead causes its neurotoxicity. Lead is known to cause myelin defects, although the mechanism is unclear. Myelin in the central nervous system is formed by oligodendrocytes, making these cells a possible target for lead. The investigators have previously demonstrated that environmentally relevant, low-level lead can disturb the survival, proliferation, and differentiation of oligodendrocytes at critical windows of development. The investigators have also demonstrated that developing oligodendrocytes are highly vulnerable to excitotoxicity mediated by Ca2+-permeable glutamate receptors (GluRs). Lead is a divalent metal ion that can mimic Ca2+ and interferes with Ca2+-sensitive targets. Mitochondria play a major role in buffering intracellular Ca2+, and are a known Pb2+ target. Here we propose to examine the hypothesis that a critical factor in lead neurotoxicity is the impairment of Ca2+-permeable GluR function and alteration of developmental GluR expression, concurrently with deficits in signaling mechanisms involving altered mitochondrial dynamics and redox potential in developing oligodendrocytes, resulting in aberrant neuron-glia connectivity and functional impairments. Aim 1 of this proposal will examine whether Pb2+ inhibits Ca2*-permeable GluR function in developing oligodendrocytes, and determine the relative roles of GluR subtypes in Pb2+ toxicity. Aim 2 will determine whether lead exposure modifies GluR subunit expression and phosphorylation state, and downstream signaling molecules that regulate GluR function. Aim 3 will determine whether Pb2+ causes alterations in mitochondrial function, maturation, dynamics effusion and fission, and redox state in developing oligodendrocytes. Overall, the Principal Investigator proposes to use a combination of cellular and molecular techniques applied to both in vitro and in vivo models of lead exposure, to provide overlapping approaches to unravel novel mechanisms of lead-induced toxicity to the developing brain. This project is the first to study the role of GluRs and mitochondria of developing oligodendroglia in lead toxicity. Elucidating these previously unrecognized mechanisms of Pb2+ action will provide insights into understanding the risks associated with lead exposure and the development of intervention strategies of targeting Ca2+-permeable GluRs and associated signaling pathways for dealing with lead toxicity.
期刊论文(31)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.brainres.2015.09.023
发表时间:
2016-05-01
期刊:
Brain research
影响因子:
2.9
作者:
[Liu Y, Deng W]
通讯作者:
Deng W
DOI:
10.1038/srep22556
发表时间:
2016-03-01
期刊:
Scientific reports
影响因子:
4.6
作者:
[Daugherty DJ, Chechneva O, Mayrhofer F, Deng W]
通讯作者:
Deng W
Switching cell fate: the remarkable rise of induced pluripotent stem cells and lineage reprogramming technologies.
转换细胞命运:诱导多能干细胞和谱系重编程技术的显着崛起。
DOI:
10.1016/j.tibtech.2010.01.002
发表时间:
2010-04
期刊:
TRENDS IN BIOTECHNOLOGY
影响因子:
17.3
作者:
[Selvaraj, Vimal, Plane, Jennifer M., Williams, Ambrose J., Deng, Wenbin]
通讯作者:
Deng, Wenbin
DOI:
10.3791/1951
发表时间:
2010-05-18
期刊:
Journal of visualized experiments : JoVE
影响因子:
--
作者:
[Shen, Yan, Plane, Jennifer M, Deng, Wenbin]
通讯作者:
Deng, Wenbin
DOI:
10.1038/cddis.2015.119
发表时间:
2015-05-07
期刊:
Cell death & disease
影响因子:
9
作者:
[Chung SH, Biswas S, Selvaraj V, Liu XB, Sohn J, Jiang P, Chen C, Chmilewsky F, Marzban H, Horiuchi M, Pleasure DE, Deng W]
通讯作者:
Deng W
共 21 条
Differentiation and Integration of Trisomy 21 iPSCs in an Animal Model
-
批准号:9538075
-
项目类别:
-
资助金额:$32.58万
-
财政年份:2017
-
负责人:Wenbin Deng
-
依托单位:
Regenerating CNS white matter using induced pluripotent stem cells
-
批准号:9077989
-
项目类别:
-
资助金额:$32.54万
-
财政年份:2016
-
负责人:Wenbin Deng
-
依托单位:
Glutamate Receptors in Hypoxic-ischemic Injury to Developing Oligodendrocytes
-
批准号:8039901
-
项目类别:
-
资助金额:$27.01万
-
财政年份:2008
-
负责人:Wenbin Deng
-
依托单位:
Glutamate Receptors in Hypoxic-ischemic Injury to Developing Oligodendrocytes
-
批准号:8253731
-
项目类别:
-
资助金额:$27.01万
-
财政年份:2008
-
负责人:Wenbin Deng
-
依托单位:
Glutamate Receptors in Hypoxic-ischemic Injury to Developing Oligodendrocytes
-
批准号:7560011
-
项目类别:
-
资助金额:$27.56万
-
财政年份:2008
-
负责人:Wenbin Deng
-
依托单位:
Glutamate Receptors in Hypoxic-ischemic Injury to Developing Oligodendrocytes
-
批准号:7463517
-
项目类别:
-
资助金额:$27.56万
-
财政年份:2008
-
负责人:Wenbin Deng
-
依托单位:
Glutamate Receptors in Hypoxic-ischemic Injury to Developing Oligodendrocytes
-
批准号:7795706
-
项目类别:
-
资助金额:$27.29万
-
财政年份:2008
-
负责人:Wenbin Deng
-
依托单位:
Oligodendrocytes, Glutamate Receptors, and Lead Neurotoxicity
-
批准号:7632253
-
项目类别:
-
资助金额:$33.96万
-
财政年份:2007
-
负责人:Wenbin Deng
-
依托单位:
Oligodendrocytes, Glutamate Receptors, and Lead Neurotoxicity
-
批准号:7487876
-
项目类别:
-
资助金额:$46.86万
-
财政年份:2007
-
负责人:Wenbin Deng
-
依托单位:
Oligodendrocytes, Glutamate Receptors, and Lead Neurotoxicity
-
批准号:7337480
-
项目类别:
-
资助金额:$47.46万
-
财政年份:2007
-
负责人:Wenbin Deng
-
依托单位:
Oligodendrocytes, Glutamate Receptors, and Lead Neurotoxicity
-
批准号:7847872
-
项目类别:
-
资助金额:$9.8万
-
财政年份:2007
-
负责人:Wenbin Deng
-
依托单位:
国内基金
海外基金
登录
查看更多内容
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
-
批准号:22007039
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王黎明
-
依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:朱义广
-
依托单位:
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
-
批准号:21372217
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:袁伟成
-
依托单位:
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
-
批准号:21172061
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2011
-
负责人:许新华
-
依托单位:
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
-
批准号:21176225
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:童少平
-
依托单位:
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
-
批准号:81072511
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2010
-
负责人:严江伟
-
依托单位:
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
-
批准号:30660215
-
项目类别:地区科学基金项目
-
资助金额:21.0万元
-
批准年份:2006
-
负责人:王世范
-
依托单位: